RGEN News and Press, Repligen Corporation From 04/18/23

WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2023 financial results on Tuesday, May 2, 2023. The Company will issue a press release before the market opens and will host a conference call at 8:...

2023-04-13 00:30:00 ET Summary In the Russell 1,000, 33 names are up more than 1,000% since April 12th, 2013. Over the same 10-year period, the S&P 500 tracking ETF is up 211%. The obvious next question is: which stocks will be ten baggers over the next ten years? ...

2023-04-12 11:48:39 ET Repligen ( NASDAQ: RGEN ) stock rose ~4% on Wednesday after the company said it was acquiring FlexBiosys in a cash and equity transaction. The company said it executed an equity purchase agreement  with FlexBiosys, TSAP Holdings (NJ Seller), Gay...

2023-04-04 23:00:00 ET Summary LRT Capital is a fundamental investment hedge fund. Our sole aim in crafting our investment program is to maximize long-term investment returns. March was a very good month for our strategy. Our core holdings were close to flat overall while our hedg...

2023-04-03 05:21:52 ET Goldman Sachs is sticking with its S&P 500 ( SP500 ) ( NYSEARCA: SPY ) target of little change by year end as valuations and earnings face headwinds near term, its equity team said. "Our Long Duration basket has outperformed the Short Duration bask...

2023-03-12 10:23:23 ET Summary Repligen's exclusive partnerships with companies such as DRS Daylight Solutions and Purolite give it a competitive edge in the industry. The company's diverse product line includes pre-packed columns, alternating tangential flow, tangential flow filt...

Start Time: 08:30 End Time: 09:37 Repligen Corporation (RGEN) Q4 2022 Earnings Conference Call February 22, 2023, 08:30 AM ET Company Participants Tony Hunt - President and CEO Jon Snodgres - CFO Sondra Newman - Head, IR Conference Call Participants ...

Repligen press release ( NASDAQ: RGEN ): Q4 Non-GAAP EPS of $0.68 beats by $0.10 . Revenue of $186.76M (+0.1% Y/Y) beats by $2.35M . YEAR 2023 GUIDANCE: Total reported revenue is expected to be in the range of $760-$800 million vs. $800.24M consensus. This guid...

Fourth quarter revenue of $186.8 million represents year-over-year organic growth of 4% and 5% growth at constant currency Full year revenue of $801.5 million represents year-over-year organic growth of 22% and 25% growth at constant currency Base business organic growth was 35%...

Repligen ( NASDAQ: RGEN ) is scheduled to announce Q4 earnings results on Wednesday, February 22nd, before market open. The consensus EPS Estimate is $0.58 (-28.4% Y/Y) and the consensus Revenue Estimate is $184.41M (-1.1% Y/Y). Over the last 2 years, RGEN has beaten EPS est...